IntriCon Corporation (IIN) News
Filter IIN News Items
IIN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest IIN News From Around the Web
Below are the latest news stories about INTRICON CORP that investors may wish to consider to help them evaluate IIN as an investment opportunity.
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates IIN, VEC, SWM, BFCNEW YORK, April 06, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: IntriCon Corporation (NASDAQ: IIN )''s sale to an affiliate of Altaris Capital Partners, LLC for $24.25 per share. If you are an IntriCon shareholder, click here to learn more about your rights and options . Vectrus, Inc. (NYSE: VEC )''s merger with The Vertex Company. If you are a Vectrus shareholder, click here to learn more about … Full story available on Benzinga.com |
TTDKY vs. IIN: Which Stock Should Value Investors Buy Now?TTDKY vs. IIN: Which Stock Is the Better Value Option? |
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates VEC, IIN, WLL, OASNEW YORK, March 22, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Vectrus, Inc. (NYSE: VEC )''s merger with The Vertex Company. If you are a Vectrus shareholder, click here to learn more about your rights and options . IntriCon Corporation (NASDAQ: IIN )''s sale to an affiliate of Altaris Capital Partners, LLC for $24.25 per share. If you are an IntriCon shareholder, Full story available on Benzinga.com |
INTRICON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intricon Corporation - IINNEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Intricon Corporation (NasdaqGM: IIN) to an affiliate of Altaris Capital Partners, LLC. Under the terms of the proposed transaction, shareholders of Intricon will receive only $24.25 in cash for each share of Intricon that they own. KSF is seeking to determine whether this consideration and the process that led |
Colliers Securities Downgrades Intricon (IIN) to HoldColliers Securities analyst Kyle Bauser downgraded Intricon (IIN – Research Report) to Hold today. The company's shares closed last Monday at $23.93. According to TipRanks.com, Bauser is ranked 0 out of 5 stars with an average return of -6.4% and a 34.7% success rate. Bauser covers the Healthcare sector, focusing on stocks such as Apollo Medical Holdings, Chembio Diagnostics, and Semler Scientific. Intricon has an analyst consensus of Moderate Buy, with a price target consensus of $25.00. See today’s best-performing stocks on TipRanks >> The company has a one-year high of $28.16 and a one-year low of $12.47. Currently, Intricon has an average volume of 28.81K. |
Why Are Intricon Shares Surging MondayAltaris Capital Partners LLC will acquire Implantable device maker Intricon Corporation (NASDAQ: IIN ) for $24.25 per share in a transaction that values Intricon at an equity value of approximately $241 million . The purchase price represents a premium of approximately 39% … Full story available on Benzinga.com |
42 Stocks Moving In Monday''s Mid-Day SessionGainers Mullen Automotive, Inc. (NASDAQ: MULN ) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development. Renewable Energy Group, Inc. (NASDAQ: REGI ) shares jumped 38.7% to $60.75 after Chevron Corp (NYSE: CVX ) announced an agreement to acquire the company. IntriCon Corporation (NASDAQ: IIN ) gained 37.3% to $23.91 after the company agreed to be acquired by an affiliate of Altaris Capital Partners for $241 million. IntriCon also posted Q4 EPS of $0.23. NeuroSense Therapeutics Ltd. (NASDAQ: NRSN ) climbed 30.5% to $2.01 after gaining around 8% on Friday. First Horizon Corporation (NYSE: FHN ) shares climbed 30.4% to $23.80 after TD announced acquisition of the company for $25 per share in cash. Imperial Petroleum Inc. (NASDAQ: IMPP ) sha... |
Shareholder Alert: Ademi LLP investigates whether Intricon Corporation has obtained a Fair Price in its transaction with Altaris.MILWAUKEE, Feb. 28, 2022 /PRNewswire/ -- Ademi LLP is investigating Intricon (NASDAQ: IIN) for possible breaches of fiduciary duty and other violations of law in its transaction with Altaris. Click here to learn how to join the action: https://www.ademilaw.com/case/intricon-corporation or… |
IntriCon, NeuroSense top healthcare gainers; Aurinia, Lexicon lead losers'' packIntriCon IIN +37%. NeuroSense Therapeutics (NRSN) +28%. Aurinia Pharmaceuticals AUPH -29%. Lexicon Pharmaceuticals LXRX -24%. |
IntriCon Corporation (IIN) Q4 Earnings and Revenues Surpass EstimatesIntriCon Corporation (IIN) delivered earnings and revenue surprises of 2,200% and 6.18%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |